No results found for “”
No results found for filter “”
-
Statements & press releases 03.04.20
Europe’s COVID-19 battle: Update on the supply of medicines to the patients that need them
EFPIA member companies are working around the clock to increase capacity and ensure supply of critical medicines to patients across Europe
Read Article -
Blog articles 02.04.20
COVID-19 – A multiplier impact on the diabetes community (Guest blog)
While focusing on immediate priorities and public health emergencies, we should all already start learning from this crisis and derive key imperatives...
Read Article -
Statements & press releases 01.04.20
European research-based industry publishes commitments on tackling COVID-19
With Europe at the epicentre of the COVID-19 crisis, the researched-based pharmaceutical industry is coming together to commit its resources, expertise...
Read Article -
Blog articles 01.04.20
Trade policy and COVID-19: Openness and cooperation in times of a pandemic
In order to beat the pandemic, we need global cooperation, sharing resources, and significant investments
Read Article -
Blog articles 30.03.20
Pharma volunteering during Covid-19 crisis (Guest blog)
A blog from Innovative Pharmaceutical Initiative – iF!, the Croatian association of innovative pharmaceutical manufacturers
Read Article -
Blog articles 30.03.20
Patient Organisations and Europe’s fight against COVID-19: Industry – let’s step up
In the midst of this unprecedented situation patients communities represent, and care for, those most vulnerable to the impact of COVID-19.
Read Article -
Statements & press releases 27.03.20
Europe’s fight against COVID-19: EFPIA welcomes last night’s Statement of the Members of the European...
We stand shoulder to shoulder with Heads of States and European governments in their efforts to limit the spread of the virus, provide medical equipment,...
Read Article -
Statements & press releases 27.03.20
Europe’s COVID-19 battle: Update on the supply of medicines to the patients that need them
Earlier today, EFPIA participated in the third of what are now weekly calls with Health Commissioner Kyriakides, Commissioner Breton and Commissioner Lenarčič....
Read Article -
Blog articles 26.03.20
#COVID19 and cancer (Guest blog)
An open letter from Bettina Ryll to all cancer patient advocates
Read Article -
Blog articles 25.03.20
COVID-19 – Fighting the fakes
In times of crisis like the current COVID-19 pandemic, unfortunately, there is always someone looking to make a quick buck.
Read Article -
Blog articles 24.03.20
Leadership at times of uncertainty (Guest blog)
Dealing with the challenges of operating in a VUCA environment
Read Article -
EFPIA News 23.03.20
Coronavirus – your questions answered
What is the industry in Europe doing to help in the fight against the coronavirus? What are the risks of drug shortage caused by the coronavirus?
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 23.03.20
Coronavirus – your questions answered
What is the industry in Europe doing to help in the fight against the coronavirus? What are the risks of drug shortage caused by the coronavirus?
Read Article -
EFPIA News 05.03.20
Connecting Healthcare Awards 2020 – Apply Now
Turn the spotlight on collaborative projects that make a difference to patients across Europe
Read Article -
EFPIA News 05.03.20
EFPIA's input to the EU's Beating Cancer Plan Roadmap consultation
The research-based pharmaceutical industry remains committed to improving cancer prevention, diagnosis, treatment and quality of life of patients.
Read Article -
EFPIA News 20.02.20
IMI opens registrations for a webinar on the Coronavirus Call
The Innovative Medicines Initiative to launch EUR 45 million Call for proposals on COVID-19 early March
Read Article -
EFPIA News 10.02.20
EFPIA, Medicines for Europe and AESGP call for a Mutual Recognition Agreement on Good Manufacturing Practice...
The pharmaceutical industry in Europe has worked to support the EU27 and UK to reach an agreement that will allow patients to receive medicines and medical...
Read Article -
EFPIA News 26.09.19
A European Cancer Plan: Make it disruptive!
Cancer patient outcomes vary widely across Europe – the European Health Forum Gastein will explore how to bring the best care to all
Read Article -
EFPIA News 11.09.19
Mission Letter from EU President-elect Ursula von der Leyen to Stella Kyriakides, Commissioner-designate...
We look forward to working with Commissioner Kyriakides and her team, as well as colleagues in Member States to ensure access and availability of new treatments...
Read Article -
EFPIA News 25.07.19
Unleashing the potential of data to improve cancer care
Report from the Oncology Data Summit
Read Article -
EFPIA News 25.07.19
A busy year, before a hectic autumn
Our Oncology Platform has tackled several topics from big data and AI to drug pricing and improving patient outcomes.
Read Article -
EFPIA News 06.02.19
Open Letter from EFPIA President Dr Stefan Oschmann on the SPC manufacturing waiver
For our sector, it is essential that Europe's world-class protection of intellectual property rights be guaranteed in future. We are deeply concerned that...
Read Article -
EFPIA News 26.09.18
The Value of Health: Improving Outcomes
More effective, patient-centred, and sustainable health systems: the benefits of health outcomes measurement
Read Article -
EFPIA News 07.08.18
Exploring the science and innovation behind #WeWontRest
A new partnership with ITN Productions
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 03.04.20
Europe’s COVID-19 battle: Update on the supply of medicines to the patients that need them
EFPIA member companies are working around the clock to increase capacity and ensure supply of critical medicines to patients across Europe
Read Article -
Statements & press releases 01.04.20
European research-based industry publishes commitments on tackling COVID-19
With Europe at the epicentre of the COVID-19 crisis, the researched-based pharmaceutical industry is coming together to commit its resources, expertise...
Read Article -
Statements & press releases 27.03.20
Europe’s fight against COVID-19: EFPIA welcomes last night’s Statement of the Members of the European...
We stand shoulder to shoulder with Heads of States and European governments in their efforts to limit the spread of the virus, provide medical equipment,...
Read Article -
Statements & press releases 27.03.20
Europe’s COVID-19 battle: Update on the supply of medicines to the patients that need them
Earlier today, EFPIA participated in the third of what are now weekly calls with Health Commissioner Kyriakides, Commissioner Breton and Commissioner Lenarčič....
Read Article -
Statements & press releases 23.03.20
Europe’s COVID-19 battle: Update on the supply of medicines to the patients that need them
At this point EFPIA members do not anticipate impacts to their supply chains unless disruption due to the COVID-19 outbreak is sustained over several months....
Read Article -
Statements & press releases 18.03.20
Europe’s COVID-19 battle: working together to ensure the supply of medicines to the patients that need...
EFPIA warmly welcomes this week’s adoption of a range of measures aimed at maintaining the free circulation of medicines around Europe.
Read Article -
Statements & press releases 13.03.20
Tackling COVID-19: EFPIA welcomes proactive and regular dialogue with Commissioners on the supply of...
EFPIA joined a call with Health Commissioner Kyriakides, Commissioner Breton and Commissioner Lenarčič to discuss the potential impact of the coronavirus...
Read Article -
Statements & press releases 11.03.20
EFPIA update on research-based pharmaceutical industry response to COVID-19
The advent of a global health emergency such as coronavirus underlines the need for a collaborative, dynamic, responsive and empowered research eco-system...
Read Article -
Statements & press releases 10.03.20
EFPIA response to the publication of the EU Industrial Strategy
EFPIA notes the publication of the Industrial Strategy by the European Commission including a reference to the roadmap to the EU Pharmaceutical Strategy,...
Read Article -
Statements & press releases 25.02.20
European pharmaceutical industry response to COVID-19
As the impact of COVID-19 continues to be felt across the world, the biopharmaceutical industry in Europe remains committed to global efforts to care for...
Read Article -
Statements & press releases 04.02.20
Joining the fight against coronavirus
We have issued a call to EFPIA members to identify suitable assets in their libraries that could be utilized in the fight against coronaviruses.
Read Article -
Statements & press releases 22.01.20
EFPIA statement on CJEU ruling on clinical trial transparency
EFPIA notes the decision by the Court of Justice of the European Union (CJEU) in the case of PTC Therapeutics International v EMA (C-175/18 P) and MSD...
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 02.04.20
COVID-19 – A multiplier impact on the diabetes community (Guest blog)
While focusing on immediate priorities and public health emergencies, we should all already start learning from this crisis and derive key imperatives...
Read Article -
Blog articles 01.04.20
Trade policy and COVID-19: Openness and cooperation in times of a pandemic
In order to beat the pandemic, we need global cooperation, sharing resources, and significant investments
Read Article -
Blog articles 30.03.20
Pharma volunteering during Covid-19 crisis (Guest blog)
A blog from Innovative Pharmaceutical Initiative – iF!, the Croatian association of innovative pharmaceutical manufacturers
Read Article -
Blog articles 30.03.20
Patient Organisations and Europe’s fight against COVID-19: Industry – let’s step up
In the midst of this unprecedented situation patients communities represent, and care for, those most vulnerable to the impact of COVID-19.
Read Article -
Blog articles 26.03.20
#COVID19 and cancer (Guest blog)
An open letter from Bettina Ryll to all cancer patient advocates
Read Article -
Blog articles 25.03.20
COVID-19 – Fighting the fakes
In times of crisis like the current COVID-19 pandemic, unfortunately, there is always someone looking to make a quick buck.
Read Article -
Blog articles 24.03.20
Leadership at times of uncertainty (Guest blog)
Dealing with the challenges of operating in a VUCA environment
Read Article -
Blog articles 23.03.20
Pharma boss: EU will have to focus on long-term medical research ecosystem
In an interview with Euractiv, Nathalie Moll said that EFPIA members are working around the clock to find vaccines, diagnostics and treatments to use in...
Read Article -
Blog articles 18.03.20
Europe’s COVID-19 battle: supply, support and the search for diagnostics, vaccines, treatments and cures...
In any health emergency from HIV to SARS, Ebola to the coronavirus, attention turns to the research-based biopharmaceutical industry to discover and develop...
Read Article -
Blog articles 11.03.20
The EU’s Industrial Strategy: Will Europe smile or will she not smile; that is the question
What the EU’s industrial policy can do is enhance the strengths already present in the EU economy and create a stronger and more innovation-friendly framework...
Read Article -
Blog articles 09.03.20
EU Industrial and Pharmaceutical Strategy: An Opportunity to Drive Europe’s Health and Growth
We have outlined steps we believe that Europe can and should take and we look forward to engaging with all stakeholders in the coming months to realise...
Read Article -
Blog articles 05.03.20
Women’s health: Beating cancer in Europe
We’re committed to fighting cancer on International Women’s Day – and every day
Read Article